scieee Science in your language
[en] (orig)

The CLU-files: disentanglement of a mystery.

Abstract

The multifaceted protein clusterin (CLU) has been challenging researchers for more than 35 years. The characterization of CLU as a molecular chaperone was one of the major breakthroughs in CLU research. Today, secretory clusterin (sCLU), also known as apolipoprotein J (apoJ), is considered one of the most important extracellular chaperones ever found. It is involved in a broad range of physiological and pathophysiological functions, where it exerts a cytoprotective role. Descriptions of various forms of intracellular CLU have led to further and even contradictory functions. To untangle the current state of knowledge of CLU, this review will combine old views in the field, with new discoveries to highlight the nature and function of this fascinating protein(s). In this review, we further describe the expression and subcellular location of various CLU forms. Moreover, we discuss recent insights into the structure of CLU and assess how structural properties as well as the redox environment determine the chaperone activity of CLU. Eventually, the review connects the biochemistry and molecular cell biology of CLU with medical aspects, to formulate a hypothesis of a CLU function in health and disease.

Read accessible full text

The CLU-files: disentanglement of a mystery.

Author: Rohne, Philipp,Prochnow, Hans,Koch-Brandt, Claudia
Year: 2016
DOI: 10.1515/bmc-2015-0026
Source: https://repository.helmholtz-hzi.de/bitstream/10033/621279/1/Rohne%20et%20al.pdf
BioMol Concep s 2016; 7(1): 1–15
*Co esponding au ho : Philipp Rohne, Ins i u e o Pha macy
and Biochemis y, The apeu ical Li e Sciences – Ins i u e o
Biochemis y, Johann-Joachim-Beche Weg 30, D-55128 Mainz,
Ge many, e-mail: philipp[email p o ec ed]
Hans P ochnow: Ins i u e o Pha macy and Biochemis y,
The apeu ical Li e Sciences – Ins i u e o Biochemis y,
Johann-Joachim-Beche Weg 30, D-55128 Mainz, Ge many; and
Depa men o Chemical Biology, Helmhol z Cen e o In ec ion
Resea ch GmbH, D- B aunschweig, Ge many
Claudia Koch-B and : Ins i u e o Pha macy and Biochemis y,
The apeu ical Li e Sciences – Ins i u e o Biochemis y,
Johann-Joachim-Beche Weg 30, D-55128 Mainz, Ge many
Re iew Open Access
Philipp Rohne*, Hans P ochnow and Claudia Koch-B and
The CLU- iles: disen anglemen o a mys e y
DOI 10.1515/bmc-2015-0026
Recei ed Oc obe 1, 2015; accep ed No embe 5, 2015
Abs ac : The mul i ace ed p o ein clus e in (CLU) has
been challenging esea che s o mo e han 35 yea s. The
cha ac e iza ion o CLU as a molecula chape one was
one o he majo b eak h oughs in CLU esea ch. Today,
sec e o y clus e in (sCLU), also known as apolipop o ein
J (apoJ), is conside ed one o he mos impo an ex a-
cellula chape ones e e ound. I is in ol ed in a b oad
ange o physiological and pa hophysiological unc ions,
whe e i exe s a cy op o ec i e ole. Desc ip ions o a i-
ous o ms o in acellula CLU ha e led o u he and e en
con adic o y unc ions. To un angle he cu en s a e o
knowledge o CLU, his e iew will combine old iews
in he ield, wi h new disco e ies o highligh he na u e
and unc ion o his ascina ing p o ein(s). In his e iew,
we u he desc ibe he exp ession and subcellula loca-
ion o a ious CLU o ms. Mo eo e , we discuss ecen
insigh s in o he s uc u e o CLU and assess how s uc-
u al p ope ies as well as he edox en i onmen de e -
mine he chape one ac i i y o CLU. E en ually, he e iew
connec s he biochemis y and molecula cell biology o
CLU wi h medical aspec s, o o mula e a hypo hesis o a
CLU unc ion in heal h and disease.
Keywo ds: Alzheime ’s disease; apolipop o ein J; clus-
e in; LDL- ecep o s; molecula chape ones.
In oduc ion: clus e in (CLU),
i s his o y and he challenge o
esea che s
In he yea 1979, a p o ein was i s disco e ed, whose
complexi y, abundance and in ol emen was ini ially
unknown (1). La e , his sul a ed glycop o ein was iden i-
ied by i ue o i s blood cell agg ega ing abili y in i o,
and was he e o e named clus e in (CLU) (2). Mos s ik-
ingly, i su aced in a b oad spec um o issues and is
o e exp essed in he ace o pa hological p ocesses, such
as a he oscle osis, cance and Alzheime ’s disease (3–6).
Mo eo e , CLU was ound in he bodily luids o almos
all e eb a es om zeb a ish o humans (7, 8). In acco d-
ance wi h hese indings, an ex ensi e epe oi e o names
eme ged anging om complemen lysis inhibi o (CLI)
and es os e one ep essed p os a e message-2 (TRPM-2)
o apolipop o ein J (apoJ). Ne e heless, in 1992 he name
CLU was he gene ally accep ed e m o all disco e ed
p o eins (9).
Thus a , CLU has been demons a ed o be a highly
glycosyla ed glycop o ein o 80 kDa, consis ing o wo
polypep ide chains connec ed by ou o i e disul ide
bonds (10). The p o ein is one o he mos p ominen
ex acellula chape ones. The chape one ac i i y o CLU
has been in ensi ely s udied by Ma k Wilson and his col-
leagues (11–14). In connec ion wi h i s chape one ac i i y,
CLU is desc ibed as a p o ein ha allows o he clea ing
o cellula deb is and mis olded p o eins, as well as he
clea ance o Aβ ia he blood-b ain ba ie (BBB) (15–17).
The conce ed ac ion o chape one ac i i y, sca enging-
and clea ance- unc ion, may be one basis o he cy o-
and issue p o ec i e ole o he p o ein (5, 15, 18, 19).
P e iously, i was u he shown ha he p o ein ac s as
a signaling molecule, inducing cellula p osu i al and
p oli e a o y pa hways, which may con ey ano he mech-
anism o i s cy op o ec i e unc ion (20–22).
This unde s anding o CLU (as p e iously desc ibed)
became complica ed when in acellula CLU o ms we e
desc ibed in damaged cells, in addi ion o he p edomi-
nan sec e ed o m, and a ibu ed o a di e se and e en
opposing ole (23–26). This e iew will summa ize he
©2015, Philipp Rohne e al., published by De G uy e .
This wo k is licensed unde he C ea i e Commons A ibu ion-NonComme cial-NoDe i a i es 3.0 License.
B ough o you by | Helmhol z-Zen um ü In ek ions o schung
Au hen ica ed
Download Da e | 2/15/18 10:19 AM
2      P. Rohne e al.: The CLU- iles: disen anglemen o a mys e y
biosyn hesis o CLU, i s s uc u al ea u es and chap-
e one ac i i y as well as ocus on aspec s o in acellu-
la CLU o ms o assess hei cellula and physiological
unc ion. Finally, he in ol emen o CLU in he modu-
la ion o a ious signal ansduc ion pa hways, i s ole
in he immune sys em and i s in ol emen unde pa ho-
logical condi ions, such as ischemia and nec osis will be
discussed. The goal is o summa ize cu en iews abou
CLU o enable u u e s udies o inally sol e he ‘CLU
mys e y’.
Biogenesis o clus e in (CLU)
The biosyn hesis o human sec e o y CLU (sCLU) ollows
he canonical pa hway o sec e o y p o eins (Figu e 1).
T ansla ion o CLU s a s om a s a codon loca ed on
exon 2 o he CLU-mRNA, esul ing in a p e-p op o ein
composed o 449 amino acids. The i s 22 amino acids
ep esen a signal sequence ensu ing co- ansla ional
ansloca ion in o he endoplasmic e iculum (ER). Subse-
quen ly, he signal sequence is clea ed o and ou o i e
disul ide bonds a e o med (10). He ea e , N-glycosyla ion
a six Asn- esidues (Asn86, 103, 145, 291, 354, 374) akes place
con e ing he p op o ein o a high-mannose ER-p ecu so
(p e-sec e o y CLU, psCLU) o 60kDa (27, 28). A e ans-
loca ion o he golgi-appa a us, complex ca bohyd a e
moie ies a e a ached o he ma u a ing psCLU, composed
o galac ose, ucose, mannose, N-ace ylglucosamine and
N-ace ylneu aminic acid (29–31). The esul ing 80 kDa
p o ein is u he clea ed by a u in-like p op o ein con-
e ase (FC) (amino acid ecogni ion mo i : RIVR) be ween
A g227 and Se 228 o p oduce an N- e minal α-chain and a
C- e minal β-chain which a e in e linked by disul ide
bonds (29–31). Finally, ma u e sCLU is sec e ed as a he -
e odime ic complex o wo 40-45kDa subuni s (28, 29).
Unde cellula s ess addi ional CLU o ms eme ge by
di e sion om he canonical sec e o y pa hway (Figu e1).
They encompass co e-glycosyla ed o ms, p esumably
de i ed om e o ansloca ed CLU ou o he ER (32, 33)
o in acellula o ms which ailed o be seg ega ed in o
he ER and hus a e no ca ying any suga esidues o
disul ide bonds, espec i ely (34). In addi ion, in acel-
lula o ms may a ise om al e na i e splicing e en s o
om non-canonical/al e na i e ansla ion-ini ia ion s a
si es downs eam o he ER-leade pep ide (Figu e 1) (34).
All men ioned in acellula CLU o ms a e single-chain
p o eins, since hey a e no p o eoly ically p ocessed.
FC clea age si e
Al e na i e Exon 1
(P ochnow e al. 34)
Exon 2–9
ER-Leade
Diso de ed/mol en
globule-like egion
O de ed egion
Disul ide bonds
Amphipa hic helices
O he in amolecula
in e ac ions
Ca bohyd a es
Sec e ion
Co e-glycosyla ed
CLU o m
Co ansla ional
ansloca ion
Disul ide
bonds
Complex
glycosyla ion
FC-
clea age
sCLU
High mannose
co e-glycosyla ion
Endoplasmic
Re iculum
psCLU
Cy osolic
CLU o ms
R
e
o
a
n
s
l
o
c
a
i
o
n
Figu e 1: Illus a ion o CLU biosyn hesis.
The canonical pa hway o sec e o y p o eins leads o he syn hesis o sec e o y CLU (sCLU). I unde goes p o eoly ic ma u a ion and ca ies
complex ca bohyd a e moie ies as well as disul ide bonds. Upon cellula s ess, non-canonic CLU o ms eme ge, mainly de i ed om ailed
ansloca ion, al e na i e splicing o ansla ion-ini ia ion e en s on exon 3, as well as om e o ansloca ion. All non-sec e ed CLU o ms
a e incomple ely ma u a ed. Fo de ails please see ex .
B ough o you by | Helmhol z-Zen um ü In ek ions o schung
Au hen ica ed
Download Da e | 2/15/18 10:19 AM
P. Rohne e al.: The CLU- iles: disen anglemen o a mys e y      3
S uc u e and unc ion o sec e o y
clus e in (sCLU)
S uc u e
So a , one o he mos challenging ques ions pe ains o
he s uc u e o sCLU. O e he pas h ee decades nume -
ous s udies ha e been conduc ed, bu he s uc u al p op-
e ies o sCLU a e s ill no ully unde s ood. One eason
o his lack o knowledge lies in he agg ega ing na u e
o sCLU. Besides in e ac ing wi h a ple ho a o ligands, i
agg ega es wi h i sel , o ming di-, e a- and e en highe
oligome s, depending on he pH- alue (2, 12–14, 35). In
combina ion wi h dis inc ligands, such as ib inogen,
sCLU can o m high molecula weigh complexes wi h a
pu a i e molecula mass up o 40 000kDa and a diam-
e e anging om 50 o 100nm (14). These cha ac e is-
ics oge he wi h a he e ogeneous glycosyla ion pa e n,
ende s i di icul o ob ain X- ay s uc u es o eliable
NMR spec a om pu i ied sCLU-samples (13, 36). Addi-
ionally, i is ha d o ob ain sui able p o ein samples in
su icien quan i ies (30, 36). Ne e heless, a numbe o
s udies ha e been conduc ed, which ocus on dis inc
p ope ies o sCLU and shed ligh on i s s uc u al ele-
men s (10, 13, 37–39). Beyond doub , he p ima y s uc u e
o sCLU is highly conse ed be ween di e en species,
wi h he highes homologies ound in he egions o
disul ide bonding cys eins and he FC clea age si e poin -
ing o hei signi icance ega ding sCLU- unc ion (8, 40).
Al eady a e he i s success ul isola ion o sCLU, i s
amphipa hic cha ac e was appa en (2). La e on, sec-
onda y s uc u al elemen s we e in es iga ed by means
o ci cula dich oism (CD)- and in a ed-spec oscopy (14,
30, 35, 38, 41, 42). In all o hese a p edominan α-helical
con en o up o 60% was calcula ed. In silico analyses
u he p edic ed i e amphipa hic α-helices (37). On he
e ia y s uc u e le el, sCLU is belie ed o belong o he
amily o in insically diso de ed p o eins, meaning ha
i pa ially lacks a de ined e ia y s uc u e, hus expos-
ing hyd ophobic egions, so-called mol en globule-like
domains, owa ds he ex e nal space (43). This in u n
allows o binding o o he molecules ia hyd ophobic
in e ac ions (Figu e 2A). Rema kably, sCLU sha es his
FC clea age si e
Disul ide bonds
Clien p o ein O he in amolecula
in e ac ions
Amphipa hic helices
O de ed egions
100
Clea ed sCLU
AC
B
Unclea ed sCLU
80
60
40
20
Rela i e chape oneac i i y (%)
Non-
ed.
C l Time a e
DTT emo al C l Time a e
DTT emo al
ed. 0 h 48 h Non-
ed. ed. 0 h 48 h
Di hio h ei ol
Ca bohyd a es
Diso de ed/mol en
globule-like egions
Figu e 2: Schema ic depic ion o sCLU chape one ac i i y and hypo he ical in luence o s uc u al elemen s.
Fully ma u a ed sCLU is s abilized by disul ide bonds and in amolecula in e ac ions, such as hyd ophobic in e ac ions in he egion o
amphipa hic helices (A). In con as , a i icial unclea ed sCLU elies on i s disul ide bonds and he e o e displays a high sensi i i y owa ds
educing condi ions (B). P elimina y da a show ha unclea ed sCLU pa ly egains i s chape one ac i i y a e emo al o DTT wi hin 48h
(C). The p ocedu e o sCLU pu i ica ion, DTT ea men and chape one ac i i y assay a e in acco dance wi h Rohne e al. (30). A e 12h o
incuba ion wi h o wi hou 40 mm DTT a 37°C upon gen le agi a ion, sCLU was subsequen ly used o chape one ac i i y assays (C l educ-
ing and non- educing) o DTT was subs i u ed by PBS using a Vi aspin 4 5000 MWCO PES (Sa o ius) a 4°C and used o chape one ac i i y
assays subsequen ly o a e 48h a 4°C. All chape one ac i i y assays we e pe o med in he p esence o 5 mm DTT wi h Ca alase being
he clien p o ein. Addi ionally, BSA was mixed wi h Ca alase and se ed as a nega i e con ol o calcula e he ela i e chape one ac i i y
o sCLU as desc ibed by Rohne e al. (30). Fo e alua ion, he da a o wo o h ee independen expe imen s, each wi h he mean o wo o
h ee measu emen s we e used (unpai ed - es *p < 0.05). The e o ba s co espond o he mean±s anda d e o s.
B ough o you by | Helmhol z-Zen um ü In ek ions o schung
Au hen ica ed
Download Da e | 2/15/18 10:19 AM
4      P. Rohne e al.: The CLU- iles: disen anglemen o a mys e y
ea u e wi h o he in insically diso de ed p o eins, mos
p ominen ly hea shock p o ein (Hsp) 27 o α-c ys alline
(11, 44). As poin ed ou in he ollowing, sCLU indeed pos-
sesses a chape one ac i i y simila o ha o Hsp27 and
o he hea shock p o eins.
Chape one and sca enging unc ion
Chape ones a e pa o he basic molecula de ense mech-
anism o a cell o e coming s ess si ua ions induced by
UV ligh , ionic i adia ion, hea , oxidan s, hea y me als,
hype oxia o ce ain d ugs. They can be di ided in o di e -
en classes: chape onins, Hsp100, Hsp90, Hsp70, Hsp60
and small Hsps (sHsps) (45). These in acellula chap-
e ones egula e he co ec olding o ma u ing p o eins
o p e en he agg ega ion o dena u ed p o eins hus
adop ing a cy op o ec i e unc ion. Some e en ini ia e
he e olding o mis olded p o eins in an ATP-dependen
manne (Hsp70, Hsp90, chape onins). Fo chape ones,
na i ely diso de ed egions a e equi ed o binding wi h
a ple ho a o s uc u ally di e se clien p o eins (46).
Simila o he abo e men ioned Hsps, CLU-mRNA
is up- egula ed upon cellula s ess due o a hea shock
elemen -like mo i p esen in he CLU p omo o (19, 34,
47, 48). The chape one unc ion o sCLU was e ealed
20yea s a e he p o ein’s disco e y (11). Thus i became
he i s molecula chape one known o ac ou side
o he li ing cell. Simila o sHsps inside he cell, i is
assumed ha sCLU binds o clien p o eins h ough i s
mol en globule-like egions ia hyd ophobic in e ac-
ions (13, 14, 37, 49). In pa icula , p o eins ha a e on
he o - olding pa hway, e.g. as induced by hea o educ-
ing condi ions, se e as clien s o sCLU (12, 30). The
binding occu s in an ATP-independen manne , leading
o o ma ion o soluble high molecula weigh complexes
wi h di e en mola chape one-clien a io be ween 1:5
and 1:0.33 (14, 50, 51). As a consequence, sCLU p e en s
he uncon olled agg ega ion o he dena u ing p o eins.
In e es ingly, binding o sCLU does no e ain po en-
ial enzyma ic ac i i ies o dena u ing clien p o eins.
Howe e , in coope a ion wi h ATP-dependen Hsps, such
as Hsc70, he enzyma ic ac i i y o some p o eins can be
es o ed (11, 50).
In cell cul u e expe imen s i was obse ed, ha
sCLU is able o acili a e he up ake o he bound clien
complexes in o su ounding issue cells o allow hei
emo al ia lysosomal diges ion (Figu e 3) (15, 52). Recep-
o s esponsible o he binding o sCLU and/o sCLU-p o-
ein complexes, such as megalin (15, 42, 53), LRP1 (15) and
ApoER2, VLDLR (22, 54) a e membe s o he LDL- ecep o
gene amily. In a ecen s udy, sCLU-clien complexes
we e in a enously injec ed in o mice, con i ming he
sCLU-chape one/sca enging ac i i y (17). sCLU-ligand
complexes we e ound o be en iched in he mice li e
and kidneys, which a e in ol ed in deg ada ion and sub-
sequen exc e ion o cellula oxins. The inding ha he
en ichmen in he li e can be blocked by adminis a-
ion o ucoidan (a po en inhibi o o sca enge ecep o
class A, E and F) indica es ha sCLU is able o in e ac
wi h sca enge ecep o s beside hose o he LDL- ecep-
o gene amily. In addi ion, a dec ease in he emo al o
glome ula p o ein deposi s was ound in CLU-K.O. mice
(55). In humans, educed sCLU sec e ion is accompanied
by a highe isk o Alzheime ’s disease (56). These ind-
ings a e in line wi h obse a ions ha show ha sCLU
p e en s he agg ega ion and oligome iza ion o Aβ and
ans hy e in (57, 58). Conclusi ely, hese da a a gue o
he p onounced ole o sCLU in p o ein homeos asis in
he body.
Disul ide bonds & p o eoly ic ma u a ion:
C ucial componen s o dispensable ea u es?
One o sCLU’s p ominen ea u es is i s ma u a ion in o an
α- and a β-chain occu ing wi hin he golgi appa a us o
e eb a e cells. The wo subuni s a e connec ed by 4–5
highly symme ical disul ide bonds. As sugges ed by Bon-
Hong Min’s g oup, he o ma ion o disul ide bonds is a
p e equisi e o sCLU ma u a ion/syn hesis (59).
In e es ingly, a educ ion o hese disul ide bonds
in ma u e sCLU does no inhibi i s ac i i y in chape -
one ac i i y assays (11, 12, 50). This ole ance o sCLU o
educing condi ions aises he ques ion whe he he α-
and β-chain o sCLU ac independen ly as chape ones o
whe he he disul ide bonds a e ex aneous o hei in a-
molecula associa ion. I mus be no ed ha he p ope
ma u a ion o sCLU is dependen on app op ia e disul ide
bond o ma ion. T ea men o cells wi h di hio h ei ol
(DTT), which p e en s disul ide bond o ma ion in he ER,
abolishes he sec e ion o sCLU (60). Mo e ecen ly i was
demons a ed ha mu a ions in he cys- ich egion o he
CLU p o ein a e leading o educed sec e ion o sCLU in
pa ien s wi h Alzheime ’s disease (56).
Addi ionally, i was shown ha he inhibi ion o
he p o eoly ic ma u a ion by in i o mu agenesis o
he u in-like p op o ein con e ase (FC) clea age si e,
which gene a es unclea ed sCLU, does no in e e e wi h
sCLU-ma u a ion and i s chape one ac i i y bu a he
ende s i highly sensi i e o educing condi ions (30).
The lack o p o eoly ic ma u a ion may he e o e cause
B ough o you by | Helmhol z-Zen um ü In ek ions o schung
Au hen ica ed
Download Da e | 2/15/18 10:19 AM
P. Rohne e al.: The CLU- iles: disen anglemen o a mys e y      5
an impai ed ‘ lexibili y’o sCLU (Figu e 2B). S udies o
Bailey e al. e ealed ha he N- and he C- e minus o
sCLU a e egions wi h diso de ed/mol en globule-like
domains which a e likely in ol ed in clien binding (37).
The e o e, he only egions le o s abilizing he sCLU
p o ein a e p obably he disul ide bonds and he pu a i e
amphipa hic helices nex o he FC clea age si e. As men-
ioned abo e, ma u e sCLU is s ill su icien ly ac i e e en
a e long- e m educ ion (11, 12, 30, 50). Howe e , he
ac i i y o unclea ed sCLU a e long- e m educ ion is
emendously impai ed (Figu e 2) (30). Thus, he amphi-
pa hic domains o o he neighbo ing egions may be
esponsible o sCLU p o ein s abiliza ion. In iguingly,
p elimina y da a om ou lab indica e ha unclea ed
educed sCLU pa ly egains i s chape one ac i i y when
DTT is emo ed (Figu e 2C). In conclusion, we p opose
Spe m
p o eins
Cellula p o eins
dsRNA
P dSe
P dSe
ecep o
Endocy osis
Endosome
Ac i a ion o
anc ip ion ac o s
Dab1/AKT/Co ilin
VLDLR/
ApoER2
ECM emodelling/mig a ion
Pseudomonas
ae uginosa
Su i al o
ca diomyocy es
P oli e a ion o
neu onal
p ecu so s
Modula ion o
mi ochond ial
in eg i y
Rep esen a i e cell
Lysosome
Endoplasmic
Re iculum
Au ophagosome
o ma ion
AKT/GSK3β
CLU-media ed
complexa ion
LDL- ecep o s
Nec o ic cell
Spe m cell
Complemen inhibi ion
MAC
Immune
modula ion
B ain
Blood
Figu e 3: Role o CLU in cell biology, pa hology, immunobiology and beyond.
Fo desc ip ion please see ex .
B ough o you by | Helmhol z-Zen um ü In ek ions o schung
Au hen ica ed
Download Da e | 2/15/18 10:19 AM

6      P. Rohne e al.: The CLU- iles: disen anglemen o a mys e y
ha he disul ide bonds a e on one hand impo an o
co ec olding and ma u a ion bu on he o he hand a e
no essen ial o he chape one unc ion o ma u e sCLU.
Howe e , we canno exclude he possibili y, ha hey
a e in ol ed in o he p ocesses. The la e is suppo ed
by he no ion ha sCLU is able o es o e he unc ion
o glu amine syn he ase by ac ing as a hiol speci ic-
an ioxidan . Howe e , his ac i i y is impai ed when he
disul ide bonds o sCLU a e alkyla ed o when he elec-
on dono is no hiol-based (59).
Ca bohyd a es: negligible o essen ial?
Ano he p ominen ea u e o sCLU is i s high le el o
glycosyla ion esul ing in ca bohyd a es, which com-
p ise abou 30% o he molecula weigh (61). The gly-
cosyla ion pa e n o human se um sCLU was elucida ed
in 1997. Six N-linked ca bohyd a e a achmen si es a e
ound wi hin he molecule, wi h h ee on he α- and h ee
on he β-chain in humans (29). The ca bohyd a e compo-
si ion is highly di e se and depends on he exp essing
issue (4, 31). Se um sCLU mainly con ains ca bohy-
d a e moie ies wi h sialic acid in a mono- and bian en-
na y ashion (29, 31). Simila glycosyla ion pa e ns we e
ound wi h ecombinan human sCLU (30). In con as ,
semen sCLU ca ies mainly ucose- ich glycans, enabling
semen sCLU o bind o he C- ype lec in ecep o DC-SIGN
ound on dend i ic cells. This binding was no obse ed
wi h se um sCLU (31, 62). The e o e, he glycan moie-
ies ei he change he spa ial s uc u e o sCLU so ha
i s ecep o a ini y is al e ed, o he ecep o s and o he
in e ac ing molecules ha e a ying a ini ies o dis inc
glycan moie ies.
In e es ingly, i was obse ed ha he glycosyla ion
o sCLU is c ucial o co ec pola sec e ion in epi he-
lial cells (28), bu no o chape one unc ion (41). sCLU
ea ed wi h he endoglycosidase PNGase F only showed
li le dec ease in chape one ac i i y (41). Indeed, i was
ecen ly shown ha he emo al o he e minal suga s by
exoglycosidases does nei he al e he chape one ac i i y
no he seconda y s uc u e o sCLU. Howe e , i became
ob ious ha plain PNGase F-diges ion esul s in esidual
suga s s ill being a ached o he p o ein-co e. Fully degly-
cosyla ed ecombinan human sCLU was ob ained by
applica ion o a mo e elabo a ed p o ocol and was shown
o possess a emendously dec eased chape one ac i i y.
CD-spec oscopy u he e ealed ha upon ull degly-
cosyla ion he amoun o α-helices lowe ed om 60% o
40%, whe eas he amoun o diso de ed egions inc eased
signi ican ly om abou 20% up o 30%. A e emo al
o all ca bohyd a es he ea angemen o he seconda y
s uc u e indica es ha he olding o sCLU is co ela ed
wi h i s glycosyla ion (30). In summa y, he co e-glyco-
syla ion is a p e equisi e o he olding and chape one
ac i i y o sCLU and e minal suga s migh be ins umen-
al o o he mechanisms, such as ecep o binding and
signal ansduc ion (21, 31, 62).
In acellula clus e in: signi icance
s. occu ence
Nuclea CLU (nCLU)
Since i s disco e y in he ea ly 1980s un il he mid-1990s,
CLU was ega ded solely as a sec e ed p o ein (sCLU). I
was no un il 1995 ha esea che s obse ed an associa-
ion o CLU wi h he nucleus a e induc ion o cell dea h
wi h an i-es ogens (26) o TGF-β (63). They specula ed
ha i ansla ion would s a a a s a codon loca ed on
exon 3 o he CLU-mRNA, an o he wise c yp ic nuclea
localiza ion sequence (NLS) could be ac i e. Thus, Reddy
e al. pos ula ed in e nal ansla ion ini ia ion as one pos-
sible mechanism leading o N- e minally unca ed o ms
o CLU. These unca ed o ms a e lacking he signal
sequence o seg ega ion in o he ER, exposing an NLS
and he e o e localizing CLU in he nuclea compa men
(Figu e 1). This hypo hesis, howe e , is s ill lacking sup-
po ing da a.
A ound he u n o he millennium, he g oup o Da id
Boo hman epo ed he exp ession o a nuclea o m o
CLU (nCLU) in MCF-7 cells a e ea men wi h ionizing
adia ion. They p oposed ha his nCLU o m would ac
as a p o-dea h ac o by in e ac ing wi h he DNA- epai -
associa ed p o ein Ku70. While i was ini ially assumed
ha nCLU de i es om an ER-bo ne psCLU o m (64), he
au ho s s a ed in la e publica ions ha ionizing adia-
ion a o s in e nal ansla ion ini ia ion a a s a codon
on exon 3, esul ing in he exp ession o nCLU (Figu e 1)
(24, 65). Finally, in 2003, he same g oup epo ed ha
an exon-skipping e en , esul ing in a ansc ip lacking
exon 2 wi h i s signal sequence coding egion (he ea e
e med a ian 1 [Δex2]), p ecedes he exp ession o nCLU
(25). Su p isingly, o e exp ession-expe imen s wi h
a ian 1 [Δex2] esul ed in s ong cy osolic localiza ion
o he co esponding p o ein as de e mined by con ocal
mic oscopy. Nuclea associa ions, howe e , could only
be de ec ed by o e exp ession o a i icial cons uc s
lacking dis inc po ions o a ian 1 [Δex2]. Despi e his
B ough o you by | Helmhol z-Zen um ü In ek ions o schung
Au hen ica ed
Download Da e | 2/15/18 10:19 AM
P. Rohne e al.: The CLU- iles: disen anglemen o a mys e y      7
con o e sial obse a ion, he au ho s hypo hesized ha
he p o ein ansla ed om he exon 2-lacking mRNA is
he p e-nuclea o m o nCLU. I would hen be ans-
o med in o ma u e nCLU o unknown pos - ansla ional
modi ica ions induced by ionizing adia ion. Howe e ,
expe imen al p oo o his hypo hesis is s ill missing.
Th oughou he i s decade o he 2nd millennium
many esea ch g oups claimed a nuclea localiza ion o
CLU in s essed cells, including cellula s ess induced by
a ious agen s such as E oposide (66–68), In e leukin-6,
Soma os a in (69), hea (70), Ca2+-deple ion (67, 71),
se um-s a a ion (72), TNF-α- ea men (73), indocyanine-
ea men wi h g een ea ex ac s (74), p o easome
inhibi ion (75), ea men wi h 5′-Fluo ou acil and Fas
ecep o -binding an ibodies (76) o anadium- ea men
(77). Fu he mo e, nuclea localiza ion o CLU has been
obse ed upon o e exp ession o c- os (77), In e leukin-24
(78) o pVHL (79), as well as spon aneously in un ea ed
cells (69, 76, 80–82). Addi ional o he mechanisms dis-
cussed abo e, i was a gued ha inhibi ion o sCLU
sec e ion could lead o in acellula accumula ion and
subsequen ly nuclea localiza ion (83). Howe e , dimini-
shed sec e ion and he e o e in acellula accumula ion
o CLU, as desc ibed by Be ens e al. (56), did no p o ide
any e idence o nuclea localiza ion o CLU.
Ano he poin o in ense deba e is he po en ial
exon 2-skipping o CLU-mRNA (Figu e 1). The esul ing
a ian 1 [Δex2], was commonly conside ed o explain
he occu ence o nCLU in many s udies, al hough igo -
ous mRNA-analyses ha e no been pe o med. This led
o con o e sies, as some g oups could no alida e he
exis ence o a ian 1 [Δex2] (84–86). I was specula ed
ha i s exp ession migh be limi ed o MCF-7 cells o e en
an expe imen al a i ac (75, 84–87). Howe e , P ochnow
e al. con i med he exis ence o a ian 1 [Δex2] in se e al
human cell lines using alida ed, a ian -speci ic p ime
se s o RT-PCR (34). Ye , mRNA-quan i ica ion indica ed
ha a ian 1 [Δex2] accoun s o  < 0.13% o o al CLU-
mRNA, e en in s essed cells. The exon 2-con aining
a ian 1, in con as , ep esen s he p e-dominan CLU-
mRNA ( > 99% o o al CLU-mRNA). In his s udy i was also
shown ha he p o ein encoded by a ian 1 [Δex2] local-
izes solely in he cy oplasm o uns essed and s essed
cells. In ac , e y ecen s udies suppo his obse a-
ion, challenging he heo y o a nuclea localiza ion o
CLU (32, 79, 80, 88–91). Only by inco po a ing an a i i-
cial nuclea localiza ion sequence (NLS) a he 5′-end o
a ian 1 [Δex2], a nuclea localiza ion o he ansla ed
p o ein could be achie ed (92). This in u n ende s he
exis ence o a unc ional NLS hidden in he CLU p e-
p op o ein unlikely.
CLU associa ed wi h mi ochond ia
O e he cou se o he las ew yea s, an associa ion o
CLU wi h mi ochond ia has equen ly been epo ed
and in e ac ions wi h in insic apop ose- ela ed p o eins
Bax and Bcl-xL ha e been discussed (32, 93–96). Thus, i
was specula ed, ha ei he psCLU o sCLU migh ac an i-
apop o ic by seques e ing Bax in i s inac i e s a e in he
cy osol (95, 96). Howe e , in none o hese s udies i was
in es iga ed, how ex acellula sCLU o ER/golgi- esiden
psCLU can each he cy osol in o de o bind Bax (Figu e1).
Li e al. (32) ecen ly showed ha a hypoglycosyla ed o m
o sCLU can escape he sec e o y pa hway wi h he aid o
he chape one GRP78 (BiP) and s abilize he mi ochon-
d ial memb ane o a oid pacli axel-media ed apop osis
(Figu es 1 and 3). An in e ac ion wi h Bax was, howe e ,
no in es iga ed in his s udy. O he epo s sugges ha
CLU can ac p o-apop o ic by p e en ing Bcl-xL om
binding o Bax (88, 97). The au ho s assumed ha non-
sec e ed CLU o ms simila o nCLU, a e esponsible o
his e ec . This was a ibu ed o a po en ial BH3-domain
ound in silico wi hin he nCLU-sequence (97). Howe e ,
upon o e exp ession o dis inc in acellula CLU o ms,
no p o-apop o ic p ope ies could be assigned o any case
(34). Thus, he signi icance o CLU associa ion wi h mi o-
chond ia s ill needs o be challenged.
How signi ican a e dis inc in acellula CLU
o ms?
The di e se esul s and p oposals pu o wa d in he
s udies on in acellula CLU o e he pas 20 yea s a e
inconclusi e and e en con adic o y. One eason o his
may be ha he desc ibed e ec s a e es ic ed o s essed/
damaged cells and ha he abundance o in acellula
CLU o ms is negligible (34). Mos impo an ly, o ou
knowledge, no dis inc in acellula CLU o ms ha e been
desc ibed in o he o ganisms besides humans, ye . Addi-
ionally, CLU o ms lacking ca bohyd a es and/o p o eo-
ly ic ma u a ion a e no capable o main ain a chape one
ac i i y in he cell (30). Fu he mo e, P ochnow e  al.
ound no e idence o an apop osis-modula ing e ec o
unglycosyla ed cy osolic CLU o ms. The e o e, we sugges
ha in acellula CLU o ms may acciden ly e ol e in com-
p omised cells and migh ha e no bene icial unc ion o
he cell. One excep ion may be hypoglycosyla ed psCLU
o ms e o ansloca ed om ER/golgi. These o ms ha e
been desc ibed in he cou se o modula ing mi ochond ia
in eg i y o au ophagy o p omo e cell su i al (Figu e 3)
(32, 91).
B ough o you by | Helmhol z-Zen um ü In ek ions o schung
Au hen ica ed
Download Da e | 2/15/18 10:19 AM
8      P. Rohne e al.: The CLU- iles: disen anglemen o a mys e y
Cellula challenges: om nec osis
o immunobiology and beyond
sCLU and nec osis
The exp ession o sCLU is highly co ela ed o issue
degene a ion, nec osis and edox imbalances (98,
99). The s ess-associa ed up egula ion in esponse o
UV ligh , hea -shock, oxidan s, hea y me als and in
pa icula p o eo oxic s ess is media ed by he clu p o-
mo o which con ains HSF1, NFκB and AP-1 binding si es
(100). Cy o oxic s ess can also be induced by nec osis
in neighbo ing cells (Figu e 3) (101). As a consequence,
mis olded p o eins, ee adicals, lipids and o he com-
ponen s accumula e in he ex acellula space causing
an ac i a ion o he immune sys em and a ec neighbo -
ing cells (101, 102). Rema kably, i was obse ed ha CLU
up egula ion also occu s in cul u ed cells upon exposu e
o nec o ic cell deb is (103). This up egula ion is d i en
by componen s o he nec o ic cells, such as memb anous
phospha idylse ine (P dSe ) (103) o by RNA eleased
om he cy osol (Figu e 3) (104). P dSe , unde i al con-
di ions, is es ic ed o he cy osolic side o he plasma
memb ane and is exposed o he ex acellula en i on-
men upon damage o apop osis (105). Ex acellula RNA
is endocy osed by su ounding cells and up egula es
CLU ia he TLR3-signaling pa hway (104). Once sCLU
is sec e ed in o he ex acellula space, i media es he
binding and endocy ic up ake o cellula deb is by ecep-
o s o he LDL- ecep o gene amily, such as megalin o
LRP1 hus ees ablishing he ex acellula p o eos asis
(Figu e 3) (15, 30).
sCLU and immunobiology
Qui e ecen ly, da a sugges ha semen sCLU can bind
s ess-damaged p o eins, acili a ing he up ake by den-
d i ic cells ia DC-SIGN hus making a p iming o immune
cells easible (Figu e 3) (31, 62). As a u he consequence,
sCLU has been a ibu ed o media e ole ance o he
emale geni al ac owa ds male an igens (Figu e 3) (62).
This sugges s an immune egula o y ole o sCLU, which
is e iden om mul iple in i o and in i o s udies. Ini-
ially, sCLU was ound o be co-localized wi h complemen
SC5b-9/MAC (memb ane a ack complex) in glome ulo-
neph i i is bu no in heal hy indi iduals (106). Subse-
quen ly, in associa ion wi h he SC5b-9 complex sCLU was
cha ac e ized as an inhibi o o he complemen sys em
(Figu e 3) (38, 49, 107). The complemen sys em causes cell
damage unde enal pa hologies. Thus, sCLU may alle ia e
enal inju ies by p e en ing an uncon olled MAC ac i i y
(108). Howe e , in 1999 Hochg ebe e al. (109) showed ha
complemen inhibi ion by sCLU is no possible a physi-
ological concen a ions. Despi e hese ac s, he mos
ecen da a sugges ha Pseudomonas ae uginosa can
p o ec i sel om complemen a ack by ec ui ing sCLU
(110). Simila sugges ions we e made o spe m cells in he
emale geni al ac (Figu e 3) (49). Thus, an inc ease in
he local sCLU concen a ion may achie e a complemen
inhibi ing e ec .
Addi ionally, o he da a suppo a ole o sCLU in
immune modula ion: I was shown ha sCLU syne gize
wi h IL-2 o enhance he p oli e a ion o na u al kille cells
(111). Mo eo e , sCLU is desc ibed as a ansc ip ional
a ge o he lympho oxin-β ecep o in ge minal cen e s
du ing an immune esponse (112, 113). I was u he dem-
ons a ed ha sCLU imp o ed he iabili y o B lympho-
cy es (113). In addi ion, i is impo an o no e ha CLU
was desc ibed as a necessa y ac o o cu a ion o au oim-
mune myoca di is, which is accompanied by an inc eased
le el o nec osis and in lamma ion (102, 114). These con-
clusions we e u he suppo ed by obse a ions a e
in a enously adminis a ion o sCLU in a s du ing myo-
ca dial in a c ion. A e ea men wi h sCLU, he in a c
size was signi ican ly educed and led o mac ophage
in asion (115). This inding is suppo ed by an ele a ed
chemo ac ic mig a ion o mac ophages due o inc eased
ma ix me allop o einase-9 (MMP9) exp ession induced
by sCLU ia he ERK1/2-, PI3K/AKT- and NFκB-signaling
pa hway (Figu e 3) (21, 116). The abili y o sCLU o modu-
la e mac ophage unc ion was u he con i med by an
addi ional s udy which demons a ed ha he mig a o y
e ec is ela ed o TNF-α sec e ion induced by sCLU (116).
Howe e , an Dijk e al. (20) ha e ound no e idence o
a di e ence in wound healing a e sCLU applica ion.
Ra he , sCLU p o ec s ca diomyocy es om apop osis by
inducing he PI3K/AKT-signaling pa hway (Figu e 3).
I is impo an o no e ha nei he he p o ec i e
e ec o sCLU on ca diomyocy es, he educ ion o in a c
size no he in e ac ion wi h dend i ic cells a e ela ed o
ecep o s o he LDL- ecep o gene amily (20, 62, 115). I
is he e o e impo an o emphasize ha he cha ac e iza-
ion o o he sCLU binding ecep o s is essen ial o he
un a eling o sCLU unc ion.
sCLU and issue epai
The signi icance o sCLU in issue p o ec ion/ emodeling
was ound o be impo an because o i s po en ial o
B ough o you by | Helmhol z-Zen um ü In ek ions o schung
Au hen ica ed
Download Da e | 2/15/18 10:19 AM
P. Rohne e al.: The CLU- iles: disen anglemen o a mys e y      9
p e en o gans om damage unde ischemic condi ions,
e.g. ischemia- epe usion inju y (IRI) a e ansplan-
a ion (117). The ischemia- epe usion damage occu s
when he bloods eam is ees ablished a e pe iods o
limi ed nu ien and oxygen supply. The consequence
o his mechanism leads o ini ial nec osis, ollowed
by massi e apop osis o he su ounding issue (102).
The su ounding apop osis is belie ed o be due o he
elease o ee adicals, gene a ing lipid adicals in he
cellula memb ane and he e o e causing emendous
cellula damage (Figu e 3) (101). In ac , sCLU is up eg-
ula ed a e oxida i e s ess caused by H2O2 o ciga e e
smoke, p o ec ing he cells and main aining hei iabil-
i y (19, 20, 59, 118). In he case o ansplan medicine, i
was shown ha supplemen sCLU in Uni e si y o Wis-
consin-solu ion (UW-solu ion) is easible o p olong he
handling- ime be o e an o gan can be ansplan ed (119).
Simila ly o his inding, i was obse ed ha a gene ic
inac i a ion o he CLU gene leads o an inc eased o gan
ejec ion as well as impai ed cell iabili y. These p o ec-
i e ac ions a e p obably due o inc eased memb ane lu-
idi y in he p esence o sCLU, minimizing cold-induced
s i ening and shea s ess (117). Fu he mo e, sCLU is a
candida e bioma ke o damage in he p oximal ubule
o he kidney (120). Addi ionally, i was shown ha
o e ime, he absence o sCLU leads o an inc eased
accumula ion o componen s om he immune sys em
wi hin he glome uli (55). Se e al in i o s udies sugges
a cy op o ec i e unc ion o sCLU a e gen amicin- o
H2O2-induced cy o oxici y in kidney cells (121, 122).
When inducing IRI by clamping he enal pedicles o
mice, sCLU is an essen ial ac o o enal egene a ion.
In con as o mac ophages, howe e , sCLU has no p o-
mig a o y e ec on enal ubula epi helial cells (TECs)
bu p omo es p oli e a ion and cell iabili y o TECs. In
con as o wild ype mice, CLU K.O.-animals exhibi a
ema kably dec eased su i al a e o abou 90% o 30%,
espec i ely (123). P e iously i was shown ha a e uni-
la e al u e e al obs uc ion (UUO) he p esence o sCLU
was a p e equisi e o supp ess TGF-β media ed up egu-
la ion o plasminogen ac i a o inhibi o -1 (PAI-1). PAI-1
p e en s ea angemen o he ex acellula ma ix and
hus a enua es plasmin ac i a ion leading o ib osis
(124). Howe e , in con as o Nguan e al. (123) no in lu-
ence o sCLU on p oli e a ion o apop osis on ubula
epi helial cells was obse ed. Finally, i is impo an o
men ion ha al hough Gi on e al. (121) ha e excluded
an in ol emen o megalin, he pa icipa ing ecep o s
media ing he cy op o ec i e e ec o sCLU (di ec ly o
indi ec ly) a e s ill unknown.
sCLU and he ne ous sys em
Al hough i is well es ablished ha sCLU is cy op o ec-
i e in he kidney and in he hea , he ole o sCLU in
he ne ous sys em is s ill challenging. As men ioned ini-
ially, sCLU was also desc ibed as an apolipop o ein (apoJ)
which is p esen in se um ( ee and bound o high densi y
lipop o ein (HDL) pa icles). sCLU(apoJ)-con aining HDLs
accoun o app oxima ely 2% o plasma HDLs (125) wi h
abou 20% o he ci cula ing sCLU being ac ually bound o
HDLs (126). In con as o he b ain, sCLU(apoJ)-con ain-
ing HDL pa icles in plasma a e mo e lipid- ich (38, 127).
In he mammalian b ain sCLU (apoJ) and apoE a e he wo
mos abundan apolipop o eins [ e iewed by Wang and
Eckel (128)].
In iguingly, bo h apolipop o eins a e in ol ed in
simila mechanisms, such as Alzheime ’s disease o cog-
ni i e and memo y p ocesses (18, 128–130). I is impo an
o no e ha e en hough sCLU is a cons i uen o HDLs,
which a e he only lipop o ein subclass c ossing he BBB,
only LRP1 and SR-B1 a e in ol ed in lipid homeos asis o
he b ain (128). The emaining lipop o ein ecep o s a e
in ol ed in a ple ho a o o he unc ions (128, 129).
Inside he b ain, CLU is p ima ily exp essed and
sec e ed by as ocy es bu also by o he ypes o cells, e.g.
neu ons (127, 131, 132). Upon neu onal dea h, ischemia
and wi h ad ancing age, howe e , a signi ican up egula-
ion o CLU is obse ed (7, 131, 133, 134). P e iously, i was
no clea whe he an ele a ed le el o CLU in he b ain was
help ul o ha m ul. In 2001, wo g oups pe o med b ain-
ischemia expe imen s and epo ed con adic o y esul s
(133, 134). Whe eas Han e al. (133) ound ha he absence
o CLU educes cell dea h in neona al hypoxia-ischemia,
Weh li e al. (134) obse ed a neu op o ec i e e ec o CLU
in pe manen ocal ce eb al ischemia. I is belie ed ha
hese di e en indings a e due o di e en expe imen al
se ings; mo e bene icial e ec s o CLU in i o and in i o
we e obse ed elsewhe e. Fo ins ance, b ain ischemia
induced by pe manen middle ce eb al a e y occlusion
shows hea ily impai ed issue emodeling in CLU K.O.-
animals. In wild ype animals, howe e , a signi ican
CLU up egula ion by as ocy es and inc eased mic oglia/
mac ophage in asion was de ec ed (135). In e es ingly,
ano he s udy has shown ha mic oglia ac i a ion by
sCLU leads o ch onic in lamma ion and hus neu o oxic-
i y due o obse ing an inc eased elease o ni i e oxide
and TNF-α (136). Mo eo e , sCLU in as ocy e-condi ioned
media om he hippocampus and midb ain had a con-
ibu ing e ec on cell su i al and di e en ia ion bu no
on p oli e a ion o neu al p ecu so cells (137). Howe e ,
B ough o you by | Helmhol z-Zen um ü In ek ions o schung
Au hen ica ed
Download Da e | 2/15/18 10:19 AM